Activity value 93pakistan Buyer&Supplier,Last transaction date:
2026-03-27Address: house # 593-b, street # 10, chaklala scheme iii rawalpindi,pakistan
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for genome pharmaceutcals pvt ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 68 transactions, with a transaction quantity of 21967.99 and a transaction weight of 0.
YearTransactionsQuantityWeight
202529645028.150
20266821967.990
Bill of lading data
<
1/15
>
Trade date
2026/03/27
B/L No.
——
Suppliers
sna healthcare pvt ltd.
Buyers
genome pharmaceutcals pvt ltd.
POLs
——
PODs
ipaf
Supply area
India
Purchas area
Pakistan
Weight
——
Amount
17636.850591
Hs code
29224990
Product tags
pharmaceutical raw material,baclofen
Product description
PHARMACEUTICAL RAW MATERIAL BACLOFEN
Expand
genome pharmaceutcals pvt ltd. is pakistan Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,bat,origin india.
According to the 52wmb.com global trade database, as of 2026-03-27, the company has completed 3666 international trades,
with its main trading regions covering india,other,costa rica etc.
The core products include HS29339990,HS29333990,HS29183000 etc,
often transported via ipaf,port islamabad, port rpaf etc,
and its main trading partners are hangzhou maytime bio technologies co.ltd.,zeon pharma industries pvt ltd,zeon health jindustries.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on genome pharmaceutcals pvt ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.